trial

Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes

NCTId NCT04004364

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Recruiting

Enrollment 700 (estimated)

Sponsored by Northwell Health, Early Treatment Program at Lenox Hill

Primary completion 2025-03-31

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Recruiting

Enrollment

700 (estimated)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

2020-04-01

Primary completion

2025-03-31

Eligibility

ALL · 15 Years · 40 Years

Interventions & indications

Drugs

Coordinated Specialty Care (CSC)

Indications

First Episode Psychosis

Sites

1 total

Lauderdale Lakes, United States

Facts & assertions

4 sourced

Enrollment

700

Phase

Primary Completion Date

2025-03-31

Status

RECRUITING

relationships

The graph out of here

drug

Coordinated Specialty Care (CSC)

drug

lead_sponsor

Northwell Health, Early Treatment Program at Lenox Hill

company

collaborator

National Institute of Mental Health (NIMH)

company

indication

First Episode Psychosis

indication